New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Stephanie Novacek

Director, Development

Stephanie Novacek serves as NephCure’s Director of Development, where she leads fundraising strategy, working closely with donors as partners to advance our mission. With more than 20 years experience in nonprofit work, she is passionate about building meaningful relationships that create real impact.

Stephanie is grateful to be part of NephCure, energized every day by the generosity, compassion, and dedication of this amazing community. In her free time, she can be found planning the next family adventure with her husband and three children.

Lincoln, NE

Related News

NEWS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NEWS

NephCure Specialist of the Month: Dr. Rupali Avasare

NEWS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NEWS

NephCure Specialist of the Month: Dr. Fahad Aziz

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.